Monday, May 22, 2017
Project co-funded by the European Commission in the framework of the 2nd Health Programme
Enter Title Minimize

C.3.PROCESSING

  • C.3.1. ACTIVITIES
    • C.3.1.1. Reception
    • C.3.1.2. Access to the processing facilities
    • C.3.1.3. Processing
      • C.3.1.3.1. General
      • C.3.1.3.2. Processing methods
        • C.3.1.3.2.1. Organ culture and cell culture
        • C.3.1.3.2.2. Decontamination of tissues and cells
        • C.3.1.3.2.3. Sterilization/disinfection of tissue
        • C.3.1.3.2.4. Viral inactivation
        • C.3.1.3.2.5. Prion inactivation
        • C.3.1.3.2.6. Other processes
      • C.3.1.3.3. Cross contamination
      • C.3.1.4. Quality control
        • C.3.1.4.1. Microbiological control
        • C.3.1.4.2. Other controls
      • C.3.1.5. Packaging and labelling
      • C.3.1.6. Storage / preservation
        • C.3.1.6.1. General
        • C.3.1.6.2. Methods of preservation and storage
          • C.3.1.6.2.1. Preservation and storage at +37C.
          • C.3.1.6.2.2. Preservation and storage at +4C.
          • C.3.1.6.2.3. Cryopreservation
          • C.3.1.6.2.4. Glycerolization
          • C.3.1.6.2.5. Freeze drying and dehydration
          • C.3.1.6.2.6. Other methods of preservation and storage
        • C.3.1.6.3. Storage area
      • C.3.1.7. Documentation and release
        • C.3.1.7.1. General
        • C.3.1.7.2. Release
        • C.3.1.7.3. Processing file contents
        • C.3.1.7.4. Availability for inspection
        • C.3.1.7.5. Traceability
Print  
A3f Engine ::Terms Of Use::Privacy Statement